Use of a self-expanding metallic stent to palliate esophageal neoplastic obstruction in a dog

Katherine S Hansen, Chick Weisse, Allyson C. Berent, Marilyn Dunn, Ana V. Caceres, Kim L. Todd, Jeremy S. Diroff

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Case Description-An 11-year-old spayed female Collie was evaluated because of regurgitation, dysphagia, severe ptyalism, coughing, and weight loss of approximately 12 weeks' duration. Esophageal squamous cell carcinoma had been diagnosed prior to referral on the basis of results of radiographic and endoscopic examination and histologic evaluation of biopsy samples. A percutaneous endoscopically placed gastrostomy (PEG) tube had been inserted 2 weeks prior to referral, and the dog was being treated for infection at the gastrostomy site. Clinical Findings-Physical examination findings included marked ptyalism, stertor, and inflammation and discharge at the gastrostomy site. Treatment and Outcome-Surgical options were declined by the owner, and palliative treatment was chosen to alleviate clinical signs and facilitate PEG tube removal. With fluoroscopic guidance, a self-expanding metallic stent was placed in the esophageal lumen at the site of obstruction. Botulinum toxin A was injected into the mandibular salivary glands under ultrasonographic guidance as treatment for severe ptyalism. Following discharge, clinical improvement was reported until euthanasia for unrelated disease 12 weeks after stent placement. Necropsy revealed that the stent had not migrated and had remained patent with some tumor ingrowth but no evidence of stricture or obstruction. Clinical Relevance-Esophageal stenting effectively treated obstruction and improved clinical signs and may be beneficial for palliative treatment in other animals with malignant esophageal tumors. Although the degree to which botulinum toxin A injection into salivary glands improved clinical signs could not be determined, it may potentially be useful as adjunctive treatment to reduce severe ptyalism.

Original languageEnglish (US)
Pages (from-to)1202-1207
Number of pages6
JournalJournal of the American Veterinary Medical Association
Volume240
Issue number10
DOIs
StatePublished - May 15 2012
Externally publishedYes

Fingerprint

Gastrostomy
intestinal obstruction
botulinum toxin
Stents
Dogs
salivary glands
Type A Botulinum Toxins
dogs
Salivary Glands
Palliative Care
Collie
esophageal neoplasms
Referral and Consultation
squamous cell carcinoma
patents
euthanasia
clinical examination
Euthanasia
biopsy
necropsy

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Use of a self-expanding metallic stent to palliate esophageal neoplastic obstruction in a dog. / Hansen, Katherine S; Weisse, Chick; Berent, Allyson C.; Dunn, Marilyn; Caceres, Ana V.; Todd, Kim L.; Diroff, Jeremy S.

In: Journal of the American Veterinary Medical Association, Vol. 240, No. 10, 15.05.2012, p. 1202-1207.

Research output: Contribution to journalArticle

Hansen, Katherine S ; Weisse, Chick ; Berent, Allyson C. ; Dunn, Marilyn ; Caceres, Ana V. ; Todd, Kim L. ; Diroff, Jeremy S. / Use of a self-expanding metallic stent to palliate esophageal neoplastic obstruction in a dog. In: Journal of the American Veterinary Medical Association. 2012 ; Vol. 240, No. 10. pp. 1202-1207.
@article{8f320281df87481ab6242935dd858421,
title = "Use of a self-expanding metallic stent to palliate esophageal neoplastic obstruction in a dog",
abstract = "Case Description-An 11-year-old spayed female Collie was evaluated because of regurgitation, dysphagia, severe ptyalism, coughing, and weight loss of approximately 12 weeks' duration. Esophageal squamous cell carcinoma had been diagnosed prior to referral on the basis of results of radiographic and endoscopic examination and histologic evaluation of biopsy samples. A percutaneous endoscopically placed gastrostomy (PEG) tube had been inserted 2 weeks prior to referral, and the dog was being treated for infection at the gastrostomy site. Clinical Findings-Physical examination findings included marked ptyalism, stertor, and inflammation and discharge at the gastrostomy site. Treatment and Outcome-Surgical options were declined by the owner, and palliative treatment was chosen to alleviate clinical signs and facilitate PEG tube removal. With fluoroscopic guidance, a self-expanding metallic stent was placed in the esophageal lumen at the site of obstruction. Botulinum toxin A was injected into the mandibular salivary glands under ultrasonographic guidance as treatment for severe ptyalism. Following discharge, clinical improvement was reported until euthanasia for unrelated disease 12 weeks after stent placement. Necropsy revealed that the stent had not migrated and had remained patent with some tumor ingrowth but no evidence of stricture or obstruction. Clinical Relevance-Esophageal stenting effectively treated obstruction and improved clinical signs and may be beneficial for palliative treatment in other animals with malignant esophageal tumors. Although the degree to which botulinum toxin A injection into salivary glands improved clinical signs could not be determined, it may potentially be useful as adjunctive treatment to reduce severe ptyalism.",
author = "Hansen, {Katherine S} and Chick Weisse and Berent, {Allyson C.} and Marilyn Dunn and Caceres, {Ana V.} and Todd, {Kim L.} and Diroff, {Jeremy S.}",
year = "2012",
month = "5",
day = "15",
doi = "10.2460/javma.240.10.1202",
language = "English (US)",
volume = "240",
pages = "1202--1207",
journal = "Journal of the American Veterinary Medical Association",
issn = "0003-1488",
publisher = "American Veterinary Medical Association",
number = "10",

}

TY - JOUR

T1 - Use of a self-expanding metallic stent to palliate esophageal neoplastic obstruction in a dog

AU - Hansen, Katherine S

AU - Weisse, Chick

AU - Berent, Allyson C.

AU - Dunn, Marilyn

AU - Caceres, Ana V.

AU - Todd, Kim L.

AU - Diroff, Jeremy S.

PY - 2012/5/15

Y1 - 2012/5/15

N2 - Case Description-An 11-year-old spayed female Collie was evaluated because of regurgitation, dysphagia, severe ptyalism, coughing, and weight loss of approximately 12 weeks' duration. Esophageal squamous cell carcinoma had been diagnosed prior to referral on the basis of results of radiographic and endoscopic examination and histologic evaluation of biopsy samples. A percutaneous endoscopically placed gastrostomy (PEG) tube had been inserted 2 weeks prior to referral, and the dog was being treated for infection at the gastrostomy site. Clinical Findings-Physical examination findings included marked ptyalism, stertor, and inflammation and discharge at the gastrostomy site. Treatment and Outcome-Surgical options were declined by the owner, and palliative treatment was chosen to alleviate clinical signs and facilitate PEG tube removal. With fluoroscopic guidance, a self-expanding metallic stent was placed in the esophageal lumen at the site of obstruction. Botulinum toxin A was injected into the mandibular salivary glands under ultrasonographic guidance as treatment for severe ptyalism. Following discharge, clinical improvement was reported until euthanasia for unrelated disease 12 weeks after stent placement. Necropsy revealed that the stent had not migrated and had remained patent with some tumor ingrowth but no evidence of stricture or obstruction. Clinical Relevance-Esophageal stenting effectively treated obstruction and improved clinical signs and may be beneficial for palliative treatment in other animals with malignant esophageal tumors. Although the degree to which botulinum toxin A injection into salivary glands improved clinical signs could not be determined, it may potentially be useful as adjunctive treatment to reduce severe ptyalism.

AB - Case Description-An 11-year-old spayed female Collie was evaluated because of regurgitation, dysphagia, severe ptyalism, coughing, and weight loss of approximately 12 weeks' duration. Esophageal squamous cell carcinoma had been diagnosed prior to referral on the basis of results of radiographic and endoscopic examination and histologic evaluation of biopsy samples. A percutaneous endoscopically placed gastrostomy (PEG) tube had been inserted 2 weeks prior to referral, and the dog was being treated for infection at the gastrostomy site. Clinical Findings-Physical examination findings included marked ptyalism, stertor, and inflammation and discharge at the gastrostomy site. Treatment and Outcome-Surgical options were declined by the owner, and palliative treatment was chosen to alleviate clinical signs and facilitate PEG tube removal. With fluoroscopic guidance, a self-expanding metallic stent was placed in the esophageal lumen at the site of obstruction. Botulinum toxin A was injected into the mandibular salivary glands under ultrasonographic guidance as treatment for severe ptyalism. Following discharge, clinical improvement was reported until euthanasia for unrelated disease 12 weeks after stent placement. Necropsy revealed that the stent had not migrated and had remained patent with some tumor ingrowth but no evidence of stricture or obstruction. Clinical Relevance-Esophageal stenting effectively treated obstruction and improved clinical signs and may be beneficial for palliative treatment in other animals with malignant esophageal tumors. Although the degree to which botulinum toxin A injection into salivary glands improved clinical signs could not be determined, it may potentially be useful as adjunctive treatment to reduce severe ptyalism.

UR - http://www.scopus.com/inward/record.url?scp=84860654815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860654815&partnerID=8YFLogxK

U2 - 10.2460/javma.240.10.1202

DO - 10.2460/javma.240.10.1202

M3 - Article

C2 - 22559110

AN - SCOPUS:84860654815

VL - 240

SP - 1202

EP - 1207

JO - Journal of the American Veterinary Medical Association

JF - Journal of the American Veterinary Medical Association

SN - 0003-1488

IS - 10

ER -